| MDV3100 |
| 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-benzamide |
| (CAS 915087-33-1) |
 |
| Description： |
MDV3100 is a non-steroidal androgen receptor antagonist (IC50 = 36 nM). It reduces the efficiency of nuclear translocation of the androgen receptor and impairs both its binding to DNA and the recruitment of coactivators. It is orally available and induces tumor regression in mouse models of castration-resistant human prostate cancer. It has applications in advanced cancers that remain dependent on androgen receptor signaling even in the absence of androgen. |
| Product No. |
KT00548 |
| Product Name |
MDV3100 |
| Synonyms |
Enzalutamide |
| Formal Name |
4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-benzamide |
| CAS Number |
915087-33-1 |
| Molecular Formula |
C21H16F4N4O2S |
| Formula Weight |
464.4 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Andarine
ARN-509
ASC-J9
AZD3514
BMS-564929
MK-0773
RU 58841
Ostarine |
|
